FGP
Foyston, Gordon, & Payne’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-572,656
| Closed | -$26.3M | – | 78 |
|
|
2016
Q3 | $26.3M | Sell |
572,656
-21,925
| -4% | -$1.01M | 5.09% | 3 |
|
|
2016
Q2 | $29.9M | Buy |
594,581
+26,305
| +5% | +$1.32M | 5.44% | 2 |
|
|
2016
Q1 | $30.4M | Sell |
568,276
-969
| -0.2% | -$51.9K | 5.66% | 2 |
|
|
2015
Q4 | $37.4M | Buy |
569,245
+103,030
| +22% | +$6.76M | 7.06% | 1 |
|
|
2015
Q3 | $31.2M | Sell |
466,215
-183,986
| -28% | -$12.3M | 5.81% | 1 |
|
|
2015
Q2 | $38.4M | Buy |
650,201
+13,628
| +2% | +$805K | 5.78% | 1 |
|
|
2015
Q1 | $39.7M | Buy |
636,573
+10,571
| +2% | +$659K | 5.85% | 1 |
|
|
2014
Q4 | $20.9M | Buy |
626,002
+4,051
| +0.7% | +$135K | 2.99% | 9 |
|
|
2014
Q3 | $33.4M | Sell |
621,951
-52,937
| -8% | -$2.85M | 4.8% | 2 |
|
|
2014
Q2 | $35.4M | Buy |
674,888
+313,877
| +87% | +$16.5M | 4.49% | 1 |
|
|
2014
Q1 | $19.1M | Sell |
361,011
-474,988
| -57% | -$25.1M | 2.35% | 13 |
|
|
2013
Q4 | $33.5M | Buy |
835,999
+55,415
| +7% | +$2.22M | 4.16% | 2 |
|
|
2013
Q3 | $29.5M | Buy |
+780,584
| New | +$29.5M | 3.85% | 3 |
|